NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









StoneWise

StoneWise

Private
BeijingHealthcare & Life Scienceshttps://stonewise.cn/

Last Round

Series B

Extension

Apr 12, 2021

Total Funding Raised

$120M

Company Overview

StoneWise is a drug discovery company that provides an artificial intelligence drug discovery system designed to accelerate and improve the early stages of pharmaceutical development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Medical AI, Biotechnology, ML Platforms

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Revenue Share

AI Layer

Application

Keywords

AI drug discoverysmall-molecule drug discoverydrug discovery platformde novo drug designgenerative chemistry3D molecule generationcomputer-aided drug designCADDin silico drug discoverycomputational chemistryADMET predictiondrug discovery SaaSmolecular dynamicsDMTA cycledesign-make-test-analyze cycleCRO synthesis services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

StoneWise Comparables

Compare StoneWise with similar companies based on industry and business-model similarity.

StoneWise comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MindRank
87%
Insilico Medicine
78%
Numerion Labs
77%

StoneWise Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionApr 12, 2021
Series BApr 12, 2021
Series A ExtensionSep 15, 2020
Series AMar 16, 2020
AngelJul 1, 2019

StoneWise Investors

Notable investors and investment history

StoneWise investors
InvestorRounds
Hillhouse InvestmentSeries B Extension, Series A Extension, Series B
CDH InvestmentsSeries B Extension, Series B
Legend CapitalSeries B
Lightspeed China PartnersSeries B
Susquehanna International GroupSeries B Extension, Angel, Series B
Linear CapitalSeries B Extension, Series A Extension, Series A, Series B
Eastern Bell CapitalSeries B Extension, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 12, 2021

    $100M round led by Legend Capital.

  • Apr 12, 2021

    Led by Greater Bay Area Homeland and Luminous Ventures.

StoneWise Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

StoneWise Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about StoneWise's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range13
Year Founded2018
Last FundingApr 12, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.